These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2258353)

  • 21. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Triger DR; Granai F; Woodcock J; Wise R; Imbimbo BP
    Hepatology; 1993 Oct; 18(4):847-52. PubMed ID: 8406358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAPD peritonitis and fluoroquinolones: a review.
    Janknegt R
    Perit Dial Int; 1991; 11(1):48, 53-8. PubMed ID: 2049423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
    Turc J; Eve O; Tran Van D; Wey PF; Martinez JY
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative pharmacokinetics of new quinolones.
    Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
    Drugs; 1987; 34 Suppl 1():21-5. PubMed ID: 3481323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ciprofloxacin in patients with liver cirrhosis.
    Dixit RK; Satapathy SK; Kumar R; Dhiman RK; Garg SK; Taneja S; Bhargava VK; Chawla YK
    Indian J Gastroenterol; 2002; 21(2):62-3. PubMed ID: 11990328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of three newer quinolones in pregnant and lactating women.
    Giamarellou H; Kolokythas E; Petrikkos G; Gazis J; Aravantinos D; Sfikakis P
    Am J Med; 1989 Nov; 87(5A):49S-51S. PubMed ID: 2589384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
    Smirnova LB; Sokolova VI
    Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M; Trautmann M; Borner K; Hopfenmüller W
    Chemotherapy; 1990; 36(6):385-91. PubMed ID: 2292201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR; Ljungberg B
    Rev Infect Dis; 1989; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin.
    Durmaz B; Marol S; Durmaz R; Oram O; Hepsen IF; Günal S
    Arzneimittelforschung; 1997 Apr; 47(4):413-5. PubMed ID: 9150864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution.
    Colino CI; García Turiño A; Sanchez Navarro A; Lanao JM
    Biopharm Drug Dispos; 1998 Mar; 19(2):71-7. PubMed ID: 9580344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
    Iakovlev SV; Iakovlev VP; Izotova GN
    Antibiot Khimioter; 1995 Oct; 40(10):39-47. PubMed ID: 8660120
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D; Gaudin C; Benhamou JP
    Am J Med; 1992 Apr; 92(4A):41S-44S. PubMed ID: 1316069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ofloxacin pharmacokinetics in chronic renal failure and dialysis.
    Lameire N; Rosenkranz B; Malerczyk V; Lehr KH; Veys N; Ringoir S
    Clin Pharmacokinet; 1991 Nov; 21(5):357-71. PubMed ID: 1773550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.